Q4 2018
Released Mar 12, 2019, before the open
10-K filed Mar 12, 2019, 71 days after period end · 0001493152-19-003127
Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.61M$1.61M derived+24.0% vs Q4 2017−6.5% vs Q3 2018
Net Income-$725.00K-$725.00K derivedN/M vs Q4 2017N/M vs Q3 2018
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$954,000+21.1%
Operating Incomederived-$729,000N/M
Operating Cash Flowderived-$528,000N/M
Margins · derived
Gross margin59.2%−1.4 pt vs Q4 2017
Operating margin-45.2%−14.2 pt vs Q4 2017
Net margin-45.0%−144.1 pt vs Q4 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.61M | $1.30M | $746.00K | $513.00K |
| Net Income | -$725.00K | $1.29M | -$655.00K | -$935.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR